Printer-friendly version

February 5, 2009

ANDRE PICARD

Globe and Mail

A woman taking hormone replacement therapy for the treatment of symptoms of menopause will see her risk of breast cancer drop sharply as soon as drug use is discontinued, according to a new study.

The research, published in today's edition of the New England Journal of Medicine, confirms that the longer a woman takes HRT, the greater her risk of breast cancer, and that after five years' use the risk doubles annually.

See the complete story.